Skip to content

Development of early diagnostic markers for ovarian cancer based on exosomes from different body fluids

Development of early diagnostic markers for ovarian cancer based on exosomes from different body fluids

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400095082
Enrollment
Unknown
Registered
2024-12-31
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian cancer

Interventions

Index test:Exosomes were extracted from serum, ascites/peritoneal flush fluid, and sac fluid, and transcriptomic analysis was performed on the extracted exosomes to search for differential genes

Sponsors

Affiliated hangzhou first people's hospital, zhejiang university school of medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.> = 18 years; 2. Those who need surgery due to the discovery of an ovarian mass

Exclusion criteria

Exclusion criteria: 1. History of radiotherapy, chemotherapy, targeted therapy, etc.; 2. History of malignancy; 3. Pregnancy; 4. Refusal of enrollment; 5. The primary tumor is not ovarian tissue; 6. Patients with other malignant diseases; 7. Combined with a variety of chronic diseases such as hypertension, diabetes and autoimmune diseases

Design outcomes

Primary

MeasureTime frame
RNA expression profile of exosomes;

Countries

China

Contacts

Public ContactJinyi Tong

Affiliated hangzhou first people's hospital, zhejiang university school of medicine

tongjinyi252@zju.edu.cn+86 571 56005077

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026